Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.

作者: Subham Banerjee , Jonathan Pillai

DOI: 10.1080/17425255.2019.1621289

关键词:

摘要: Introduction: Solid matrix mediated lipid nanoparticle formulations (LNFs) retain some of the best features ideal drug carriers necessary for improving oral absorption and bioavailability (BA) both hydrophilic hydrophobic drugs. LNFs with solid matrices may be typically categorized into three major types formulations, viz., nanoparticles (SLNs), nanostructured (NLCs) lipid-drug conjugate (LDC-NPs). based are, potentially, most appropriate delivery systems poorly water soluble drugs in need improved solubility, permeability, absorption, or increased BA. In addition, as are able to encapsulate a single on their excellent ability form cores shells. Interestingly, also act devices impart chemical stability various orally administered Areas covered: Aim review is forecast presentation pharmacokinetic characteristics nanocarriers which biocompatible, biodegradable non-toxic carrier efficient Efficient broadly by fact that lipophilic readily lipidic substrates capable permeating across gut epithelium following administration, subsequently delivering moiety interest more efficiently mucosal membrane. This enhances overall BA many facing challenges profile. article specifically focuses biopharmaceutical aspects such nanoformulations possible mechanisms better administration. It briefly reviews methods access efficacy drugs, regulatory interesting lipid-derived commercial concluding remark. Expert opinion: enhance

参考文章(151)
M. Muchow, P. Maincent, R.H. Müller, C.M. Keck, Production and characterization of testosterone undecanoate-loaded NLC for oral bioavailability enhancement. Drug Development and Industrial Pharmacy. ,vol. 37, pp. 8- 14 ,(2011) , 10.3109/03639045.2010.489559
Zheng Cai, Yan Wang, Li-Jun Zhu, Zhong-Qiu Liu, Nanocarriers: A General Strategy for Enhancement of Oral Bioavailability of Poorly Absorbed or Pre-Systemically Metabolized Drugs Current Drug Metabolism. ,vol. 11, pp. 197- 207 ,(2010) , 10.2174/138920010791110836
LianDong Hu, Xing Tang, FuDe Cui, Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. Journal of Pharmacy and Pharmacology. ,vol. 56, pp. 1527- 1535 ,(2010) , 10.1211/0022357044959
Vandita Kakkar, Sukhjit Singh, Dinesh Singla, Indu Pal Kaur, Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin Molecular Nutrition & Food Research. ,vol. 55, pp. 495- 503 ,(2011) , 10.1002/MNFR.201000310
Baboota Sanjula, Faisal Md Shah, Ali Javed, Ahuja Alka, None, Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement Journal of Drug Targeting. ,vol. 17, pp. 249- 256 ,(2009) , 10.1080/10611860902718672
PA Winstanley, ML Orme, The effects of food on drug bioavailability. British Journal of Clinical Pharmacology. ,vol. 28, pp. 621- 628 ,(1989) , 10.1111/J.1365-2125.1989.TB03554.X
Filipa Antunes, Fernanda Andrade, Domingos Ferreira, Hanne Mørck Nielsen, Bruno Sarmento, Models to predict intestinal absorption of therapeutic peptides and proteins. Current Drug Metabolism. ,vol. 14, pp. 4- 20 ,(2012) , 10.2174/1389200211309010004
Christopher JH Porter, William N Charman, Intestinal lymphatic drug transport: an update Advanced Drug Delivery Reviews. ,vol. 50, pp. 61- 80 ,(2001) , 10.1016/S0169-409X(01)00151-X
Jaleh Varshosaz, Majid Tabbakhian, Mahboobeh Y Mohammadi, None, Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability. Journal of Liposome Research. ,vol. 20, pp. 286- 296 ,(2010) , 10.3109/08982100903443065
Andrew J. Humberstone, William N. Charman, Lipid-based vehicles for the oral delivery of poorly water soluble drugs Advanced Drug Delivery Reviews. ,vol. 25, pp. 103- 128 ,(1997) , 10.1016/S0169-409X(96)00494-2